Antibiotic therapy of intra-abdominal infections in the era of multiresistance;Antibiotikatherapie intraabdomineller Infektionen im Zeitalter der Multiresistenz

Chirurg

Volumn 87, Issue 1, 2016, Pages 26-33

  Eckmann, C ^a  

^a Klinikum Peine GmbH   (Germany)

Author keywords

Beta lactamase; Intra abdominal infections; Postoperative peritonitis; Resistant bacteria; Tertiary peritonitis

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTIONS; HUMAN; INTRAABDOMINAL INFECTIONS; MULTIDRUG RESISTANCE; PERITONITIS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAM RESISTANCE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INTRAABDOMINAL INFECTIONS; PERITONITIS;

EID: 84954371529     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-015-0106-9     Document Type: Article

References (33)

1. Andremont A (2013) Epidemiological overview. 23rd ECCMID Berlin, Germany, April 27–30, S 87
2. Bader F, Schroeder M, Kujath P, Muhl E, Bruch HP, Eckmann C (2009) Diffuse postoperative peritonitis – value of diagnostic parameters and impact of early indication for relaparotomy. Eur J Med Res 14:1–6
3. Barie P (2008) The cost of failure. Surg Infect 9:313–315
4. Bassetti M, Marchetti M, Chakrabarti A et al (2014) A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 39:2092–2106
5. Bodmann KF, Grabein B et al (2010) Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen. Darin: Eckmann C, Isenmann R, Kujath P et al: Intraabdominelle Infektionen. Chemother J 19:217–222
6. Chavez-Tapia NC, Soares-Weiser K, Brezis N, Leibovis L (2009) Antibiotics for sponatnaeous bacterial peritonitis in cirrhotic patients. Cochrane Database Syst Rev (1):CD002232
7. de With K, Allerberger F, Amann S et al (2013) S3-Leitlinie Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. S3-Leitlinie der Deutschen Gesellschaft für Infektiologie e. V. (DGI) (federführend) in Zusammenarbeit mit den folgenden Fachgesellschaften/Verbänden/Institutionen: ADKA, DGHM, PEG, AAHP, ÖGIT, ÖGACH, RKI Berlin. AWMF-Registernummer 092/001
8. Eckmann C (2011) Einsatz von Antibiotika und Antimykotika in Prophylaxe und Therapie bei großen viszeralchirurgischen Eingriffen. Viszeralmedizin 27:50–57
9. Eckmann C, Dryden M (2010) Treatment of omplicated skin and soft tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin. Eur J Med Res 15:1–10
10. Eckmann C, Shekarriz H (2012) Antimicrobial management of complicated intra-abdominal infections caused by resistant bacteria. Eur Infect Dis 6:22–27
11. Eckmann C, Solomkin JS (2015) Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infections. Expert Opin Pharmacother 16:1–10
12. Eckmann C, Dryden M, Montravers P et al (2011) Antimicrobial treatment of „complicated“ intra-abdominal infections and the new IDSA guidelines? A commentary and an alternative European approach according to clinical definitions. Eur J Med Res 16:115–126
13. Eckmann C, Montravers P, Bassetti M et al (2013) Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies. J Antimicrob Chemother 68(Suppl 2):ii25–ii35
14. Engel C, Brunkhorst FM, Bone HG et al (2007) Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33:606–618
15. Fernandez-Cruz A, Eworo A, Alcala L et al (2009) Delay in Administration of Adequate Antimicrobial Therapy Correlates with a Worse Prognosis in an Unselected Population with Bloodstream Infection (BSI). In, 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology K–257, San Francisco
16. Grundmann H (2013) International and national spread of ESBL and carbapenem-resistant organisms. 23rd ECCMID Berlin, Germany, S 434
17. Hackel M, Hoban D, Badal R (2014) Prevalence of Extended-Spectrum Beta-Lactamases in Europe: 2004–2011. 22nd ECCMID, London, P1178
18. Kaase M, Pfennigwerth N, Szabados F et al (2013) Report of the National Reference Laboratory for Multidrug-Resistant Gram-Negative Bacteria on Carbapenemases in Germany in 2012. 23rd ECCMID Berlin, Germany, April 27–30, P1335
19. Kaki R, Elligsen M, Walker S et al (2011) Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother 66(6):1223–1230
20. Kujath P, Rodloff AC (2005) Peritonitis, 2. Aufl. Uni-Med Verlag, Heidelberg, S 13–15
21. Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596
22. Montravers P, Leroy O, Eckmann C (2015) Intra-abdominal candidiasis: it’s still a long way to get unquestionable data. Intensive Care Med 41:1682–1684
23. Nathwani D (2009) New antibiotics for the management of complicated skin and soft tissue infections: are they any better? Int J Antimicrob Agents 34(Suppl 1):S24–S29
24. Pankey GA, Sabath LD (2004) Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of grampositive bacterial infections. Clin Infect Dis 38:864–870
25. Paul M, Silbiger I, Grozinsky S et al (2006) Beta lactam antibiotic monotherapy versus lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 25:CD003344
26. Pintado V, Meije Y, Gabilondo G et al (2010) Antibiotic therapy of infections due to metallo-beta-lactamase (MBL)-producing enterobacteriaceae: a clinical study of 64 episodes. 50th ICAAC, Boston, MA, USA. Poster K-329
27. Pletz MW, Eckmann C, Hagel S et al (2015) Multiresistente Erreger – Infektionsmanagement 2015. Dtsch Med Wochenschr 140:975–981
28. RKI (2013) Vancomycin-resistente Enterokokken (VRE): aktuelle Daten und Trends zur Resistenzentwicklung aus dem NRZ für Staphylokokken und Enterokokken, 2011–2012. Epidem Bull 33:303–312
29. Sawyer RG, Claridge JA, Nathens AB et al (2015) Trial of shourt-course antimicrobial therapy for intraabdominal infection. N Eng J Med 372(21):1996–2005
30. Solomkin JS, Mazuski JE, Bradley JS et al (2010) Diagnosis and management of complicated intra-abdominal infections in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Inf Dis 50:133–164
31. Solomkin JS, Hershberger E, Miller B, Popejoy M, Friedland I, Steenbergen J, Minjung Y, Collins, S, Yuan G, Barie PS, Eckmann C (2015) Ceftolozane/Tazobactam plus Metronidazole for complicated intra-abdominal Infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial. Clin Infect Dis 60:1462–1471
32. Weigelt JA (2007) Empiric treatment options in the management of complicated intra-abdominal infections. Cleve Clin J Med 74(Suppl 4):S29–S37
33. Wong PF, Gilliam AD, Kumar S et al (2005) Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev 18:CD004539